The Commission is concerned about the causes and consequences of these new uses of psychotropic drugs, and in the present position statement, seeks to deepen its understanding of the issues at stake. [...] Medical consultations are usually short, which may hinder the exchange of information between patient and doctor, the diagnosis, the determination of the appropriate treatment and the transmission of information on medications being proposed. [...] One has only to think of: the new challenges posed by the rise of Internet and of cyber- pharmacies, that circumvent national and international regulatory frameworks and raise questions about the scientific validity of information and the safety of buying medications under unknown conditions from anonymous individuals; the approval of drugs where there is little independent verification of data pr [...] Expanded Uses of the “Medical” Type Expanded uses of the “Medical” type occur in a context of professional practices that contributes to the expanding uses of psychotropics. [...] For example, scientific uncertainty due to lack of knowledge about the brain, the roles and interactions of neurotransmitters and the modes of action of psychotropic drugs in turn provides conditions for use outside of approved indications.